Chitosan and alginate salt as biomaterials are potential natural adjuvants for killed cholera vaccine

被引:7
作者
AbdelAllah, Nourhan H. [1 ,2 ]
Gaber, Yasser [1 ,3 ]
AbdelGhani, Sameh [1 ,5 ]
Rashed, Mohamed E. [4 ]
Azmy, Ahmed F. [1 ]
机构
[1] Beni Suef Univ, Fac Pharm, Dept Microbiol & Immunol, Bani Suwayf, Egypt
[2] Egyptian Drug Author EDA, Viral Control Unit, Cairo, Egypt
[3] Mutah Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, Al Karak, Jordan
[4] Egyptian Drug Author EDA, Microbiol Dept, Cairo, Egypt
[5] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40202 USA
关键词
adjuvants; alginate; biopolymer; chitosan; cholera vaccine; IMMUNE-RESPONSES; DELIVERY-SYSTEMS; SUBSETS; CELLS;
D O I
10.1002/jbm.a.37240
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Chitosan and alginate salts are natural biopolymers that have gained recent attention in the biomedical sectors. Their properties allow them to become potential candidates as safe, cheap, and effective vaccine adjuvants. The present study aimed to enhance the immunogenic response of a current injectable killed cholera vaccine (KCV) using chitosan and alginate salt as natural adjuvants against alum. We tested KCV adjuvanted with alum, chitosan, and sodium alginate in mice. Mice were immunized intraperitoneally with KCV adjuvanted with alum, chitosan, or alginate salt and compared with a control unadjuvanted immunized group. Humoral, cellular, and functional immune responses were evaluated in all groups. The addition of adjuvants, particularly natural adjuvants, to KCV significantly improved the immune response as demonstrated by specific antibody increase, strong proliferation effects, and high protection rate against different challenge doses of cholera strains. Our findings demonstrate that chitosan and alginate salt are superior adjuvants for boosting the KCV immune response and highlights the requirement for further vaccine development.
引用
收藏
页码:2462 / 2470
页数:9
相关论文
共 39 条
  • [1] Alginate-coated chitosan nanoparticles act as effective adjuvant for hepatitis A vaccine in mice
    AbdelAllah, Nourhan H.
    Gaber, Yasser
    Rashed, Mohamed E.
    Azmy, Ahmed F.
    Abou-Taleb, Heba A.
    AbdelGhani, Sameh
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 152 : 904 - 912
  • [2] A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice
    Abu Sayeed, Md.
    Bufano, Meagan Kelly
    Xu, Peng
    Eckhoff, Grace
    Charles, Richelle C.
    Alam, Mohammad Murshid
    Sultana, Tania
    Rashu, Md. Rasheduzzaman
    Berger, Amanda
    Gonzalez-Escobedo, Geoffrey
    Mandlik, Anjali
    Bhuiyan, Taufiqur Rahman
    Leung, Daniel T.
    LaRocque, Regina C.
    Harris, Jason B.
    Calderwood, Stephen B.
    Qadri, Firdausi
    Vann, W. F.
    Kovac, Pavol
    Ryan, Edward T.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2015, 9 (07):
  • [3] Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide
    Alam, Mohammad Murshid
    Bufano, Megan Kelly
    Xu, Peng
    Kalsy, Anuj
    Yu, Y.
    Freeman, Y. Wu
    Sultana, Tania
    Rashu, Md. Rasheduzzaman
    Desai, Ishaan
    Eckhoff, Grace
    Leung, Daniel T.
    Charles, Richelle C.
    LaRocque, Regina C.
    Harris, Jason B.
    Clements, John D.
    Calderwood, Stephen B.
    Qadri, Firdausi
    Vann, W. F.
    Kovac, Pavol
    Ryan, Edward T.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (02):
  • [4] LACK OF CROSS-PROTECTION AGAINST DIARRHEA DUE TO VIBRIO-CHOLERAE-O139 (BENGAL STRAIN) AFTER ORAL IMMUNIZATION OF RABBITS WITH V-CHOLERAE-O1 VACCINE STRAIN CVD103-HGR
    ALBERT, MJ
    ALAM, K
    ANSARUZZAMAN, M
    QADRI, F
    SACK, RB
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (01) : 230 - 231
  • [5] Amin MA, 2016, EVID-BASED COMPL ALT, V2016, P1
  • [6] Cholera Caused by Vibrio cholerae O1 Induces T-Cell Responses in the Circulation
    Bhuiyan, Taufiqur Rahman
    Lundin, Samuel B.
    Khan, Ashraful Islam
    Lundgren, Anna
    Harris, Jason B.
    Calderwood, Stephen B.
    Qadri, Firdausi
    [J]. INFECTION AND IMMUNITY, 2009, 77 (05) : 1888 - 1893
  • [7] Preparation and evaluation of a freeze-dried oral killed cholera vaccine formulation
    Borde, Annika
    Larsson, Anette
    Holmgren, Jan
    Nygren, Erik
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2011, 79 (03) : 508 - 518
  • [8] The Vaccine Adjuvant Chitosan Promotes Cellular Immunity via DNA Sensor cGAS-STING-Dependent Induction of Type I Interferons
    Carroll, Elizabeth. C.
    Jin, Lei
    Mori, Andres
    Munoz-Wolf, Natalia
    Oleszycka, Ewa
    Moran, Hannah B. T.
    Mansouri, Samira
    McEntee, Craig P.
    Lambe, Eimear
    Agger, Else Marie
    Andersen, Peter
    Cunningham, Colm
    Hertzog, Paul
    Fitzgerald, Katherine A.
    Bowie, Andrew G.
    Lavelle, Ed C.
    [J]. IMMUNITY, 2016, 44 (03) : 597 - 608
  • [9] Coffin SE, 1999, J IMMUNOL, V163, P3064
  • [10] Chitin Particles Are Multifaceted Immune Adjuvants
    Da Silva, Carla A.
    Pochard, Pierre
    Lee, Chun Geun
    Elias, Jack A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (12) : 1482 - 1491